Chemours is expected to report earnings per share of $0.10 and revenue of $1.37 billion for the fourth quarter of 2024.
The company faces a potential decline in both earnings and revenue year-over-year, which could impact its stock price.
Financial metrics reveal a P/E ratio of 36.51, a debt-to-equity ratio of 6.53, and challenges in generating cash flow with a negative enterprise value to operating cash flow ratio of -21.63.
Chemours Company (NYSE:CC) is set to release its quarterly earnings on February 18, 2025. Wall Street expects the earnings per share to be $0.10, with projected revenue around $1.37 billion. Chemours, a key player in the chemical industry, specializes in titanium technologies, fluoroproducts, and chemical solutions. It competes with companies like DuPont and 3M in the market.
The anticipated earnings report for the fourth quarter of 2024 suggests a decline in both earnings and revenue for Chemours. This outlook indicates a year-over-year decrease, which could impact the stock price based on how the actual results align with these estimates. If Chemours exceeds expectations, the stock might rise, but a miss could lead to a decline.
Chemours’ financial metrics provide insight into its current market position. The company has a price-to-earnings (P/E) ratio of 36.51, showing how much investors are willing to pay per dollar of earnings. Its price-to-sales ratio is 0.44, indicating the market value relative to sales. The enterprise value to sales ratio is 1.08, reflecting the company’s total value compared to its sales.
However, Chemours faces challenges in generating cash flow, as highlighted by a negative enterprise value to operating cash flow ratio of -21.63. This suggests difficulties in producing cash flow relative to its enterprise value. The earnings yield stands at 2.74%, offering insight into the earnings generated from each dollar invested in the stock.
The company’s debt-to-equity ratio is notably high at 6.53, indicating a significant reliance on debt financing. This could pose risks if the company faces financial difficulties. On the other hand, the current ratio of 1.73 suggests Chemours can cover its short-term liabilities with its short-term assets, reflecting a stable liquidity position.
